Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

NYU Langone Health, New York

Memorial Sloan Kettering Cancer Center, New York

NEXT Oncology, Fairfax

Institut Oncopole Claudius Regaud, Toulouse

Florida Cancer Specialists & Research Institute, Lake Mary

Institut Bergonié, Bordeaux

Sarah Cannon Tennessee Oncology, Nashville

EDOG Institut de Cancerologie de l'Ouest, Saint-Herblain

Northwestern University, Chicago

Carle Cancer Center, Urbana

Washington University, St Louis

Centre Léon Bérard, Lyon

The University of Texas MD Anderson Cancer Center, Houston

Sarah Cannon Research Institute at HealthONE, Denver

Grand Valley Oncology, Grand Junction

University of California Los Angeles, Los Angeles

University of California San Francisco, San Francisco

Institute Gustav Roussy, Villejuif

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston